BMS-986393 CAR T-cell therapy for R/R multiple myeloma: results of a Phase I trial
Susan Bal • 9 Dec 2023
BMS-986393, a novel anti-GPRC5D CAR-T cell therapy, in multiple myeloma
Omar Nadeem • 28 Sep 2023
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.